APPENDIX 4C – 3RD QUARTER FY18/19 QUARTERLY REPORT
Resonance Health Limited (ASX: RHT) (“Resonance Health” or “Company”) today released its Appendix 4C – Quarterly Reportfor the period ended 31 March 2019.
Summary of Key Financials and Business Performance
• Cash receipts from customers for the March 2019 quarter were $961K, an increase of 6% versus the December 2018 quarterand an increase of 34% versus the March quarter for the previous year.
• Total revenue for the March quarter was $941K (unaudited), an increase of 10% versus the March quarter for the previousyear.
• Cash on hand as of 31 March 2019 was $2.47m, an increase of $323K over the December 2018 quarter
Bang on
Just a little above forecast
very good result
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.38M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 460 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.8¢ | 75743 | 2 |
View Market Depth
| Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
| RHT (ASX) Chart |
Day chart unavailable